Showing results (101-110 of 125) with videos related to

Sort By:
Pageof 13
Tropical Medicine & International Health : TM & IH|February 21, 2009
PCR and direct agglutination as Leishmania infection markers among healthy Nepalese subjects living in areas endemic for Kala-AzarNarayan Raj Bhattarai, Gert Van der Auwera, Basudha Khanal, et al.
BMC Infectious Diseases|December 24, 2017
Genetic diversity of Leishmania donovani that causes cutaneous leishmaniasis in Sri Lanka: a cross sectional study with regional comparisonsUdeshika Lakmini Kariyawasam, Angamuthu Selvapandiyan, Keshav Rai, et al.
Plos Neglected Tropical Diseases|September 27, 2019
Field effectiveness of new visceral leishmaniasis regimens after 1 year following treatment within public health facilities in Bihar, IndiaVishal Goyal, Sakib Burza, Krishna Pandey, et al.
Plos Neglected Tropical Diseases|August 8, 2015
Transmission of Leishmania donovani in the Hills of Eastern Nepal, an Outbreak Investigation in Okhaldhunga and Bhojpur DistrictsBart Ostyn, Surendra Uranw, Narayan Raj Bhattarai, et al.
The Journal of Infectious Diseases|July 4, 2012
Genetic markers for SSG resistance in Leishmania donovani and SSG treatment failure in visceral leishmaniasis patients of the Indian subcontinentManu Vanaerschot, Saskia Decuypere, Tim Downing, et al.
Plos Neglected Tropical Diseases|January 28, 2014
Strong association between serological status and probability of progression to clinical visceral leishmaniasis in prospective cohort studies in India and NepalEpco Hasker, Paritosh Malaviya, Kamlesh Gidwani, et al.
ACS Applied Materials & Interfaces|August 4, 2021
Effects of Cu Precursor on the Performance of Efficient CdTe Solar CellsSandip S Bista, Deng-Bing Li, Rasha A Awni, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 22, 2013
Increasing failure of miltefosine in the treatment of Kala-azar in Nepal and the potential role of parasite drug resistance, reinfection, or noncomplianceSuman Rijal, Bart Ostyn, Surendra Uranw, et al.
Clinical Microbiology Reviews|August 31, 2018
Recent Development of Visceral Leishmaniasis Treatments: Successes, Pitfalls, and PerspectivesFabiana Alves, Graeme Bilbe, Séverine Blesson, et al.
The Journal of Antimicrobial Chemotherapy|May 10, 2024
Skin pharmacokinetics of miltefosine in the treatment of post-kala-azar dermal leishmaniasis in South AsiaSemra Palić, Wan-Yu Chu, Shyam Sundar, et al.
Pageof 13